Genertec Universal Medical Group Company Limited (5UM) — Cash Flow Quality Index
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Quality Index of -2.94x as of June 2023. Operating cash flow of €-1.67 Billion is below net income of €567.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 5UM cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genertec Universal Medical Group Company Limited Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Genertec Universal Medical Group Company Limited across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Genertec Universal Medical Group Company to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Genertec Universal Medical Group Company Limited (2016–2025)
Year-by-year earnings quality comparison for Genertec Universal Medical Group Company Limited. For live market cap and the full company financial profile, see 5UM market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.61x | €5.78 Billion | €2.21 Billion | ▲ +366.7% |
| 2024 | 0.56x | €1.14 Billion | €2.03 Billion | ▼ -77.3% |
| 2023 | 2.47x | €4.99 Billion | €2.02 Billion | ▲ +127.0% |
| 2022 | 1.09x | €2.06 Billion | €1.89 Billion | ▲ +242.6% |
| 2021 | -0.76x | €-1.40 Billion | €1.84 Billion | ▼ -29.4% |
| 2020 | -0.59x | €-971.72 Million | €1.65 Billion | ▲ +48.6% |
| 2019 | -1.15x | €-1.82 Billion | €1.59 Billion | ▲ +72.9% |
| 2018 | -4.24x | €-5.73 Billion | €1.35 Billion | ▲ +4.1% |
| 2017 | -4.42x | €-5.07 Billion | €1.15 Billion | ▼ -61.7% |
| 2016 | -2.73x | €-2.38 Billion | €872.31 Million | — |